ASGCT24: Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids

Regeneron Pharmaceuticals’ investigational gene therapy DB-OTO improved hearing in two young children with “profound genetic deafness” since birth, according to the company’s Wednesday oral presentation at the 2024 American Society of Gene & Cell Therapy annual meeting in Baltimore.